Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats

Journal of Neuroscience Research

Volumn 85, Issue 10, 2007, Pages 2167-2174

  Sehara, Yoshihide ^a   Hayashi, Takeshi ^a   Deguchi, Kentaro ^a   Zhang, Hanzhe ^a   Tsuchiya, Atsushi ^a   Yamashita, Toru ^a   Lukic, Violeta ^a   Nagai, Makiko ^a   Kamiya, Tatsushi ^a   Abe, Koji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Colony stimulating factor; Granulocyte; Inflammation; Transient middle cerebral artery occlusion

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL PROLIFERATION; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; STROKE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; GRANULOCYTE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; MALE; NERVOUS SYSTEM; NEUROPROTECTIVE AGENTS; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547461194     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21341     Document Type: Article

References (60)

1. Abe K, Araki T, Kogure K. 1988. Recovery from edema and of protein synthesis differs between in the cortex and caudate following transient focal cerebral ischemia in rats. J Neurochem 51:1470-1476.
2. Bachman KE, Park BH. 2005. Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter. Curr Eye Res 26:363-370.
3. Baird AE, Benfield A, Schlaug G, Siewert B, Lovblad KO, Edelman RR, Warach S. 1997. Enlargement of human cerebral ischemic legion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol 41:581-589.
4. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ. 1997. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28:1233-1244.
5. Barone FC, Feuerstein GZ. 1999. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 19:819-834.
6. Bogousslavsky J, Victor SJ, Salinas EO, Pallay A, Donnan GA, Fieschi C, Kaste M, Orgogozo JM, Charmorro A, Desmet A. 2002. Fibroblast (trafermin) in acute stroke: results of the European-Australian phase II/ III safety and efficacy trial. Cerebrovasc Dis 14:238-251.
7. Botchkina GI, Meistrell ME III, Botchkina IL, Tracey KJ. 1997. Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med 3:765-781.
8. Buckwalter MS, Yamane M, Coleman BS, Ormerod BK, Chin JT, Palmer T, Wyss-Coray T. 2006. Chronically increased transforming growth factor-1 strongly inhibits hippocampal neurogenesis in aged mice. Am J Pathol 169:154-164.
9. Bussolino F, Wang JM, Defilippi P, Turrini F, Sanavio F, Edgell CJ, Aglietta M, Arese P, Mantovani A. 1989. Granulocyte- and granulocyte-macrophage- colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 337:471-473.
10. Cockroft KM, Meistrell M III, Zimmerman GA, Risucci D, Bloom O, Cerami A, Tracey KJ. 1996. Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 27:1393-1398.
11. Danton GH, Dietrich WD. 2003. Inflammatory mechanisms after cerebral ischemia and stroke. J Neuropathol Exp Neurol 62:127-136.
12. Dirnagl U. 1999. Pathobiology of ischemic stroke: an integrated view. Trends Neurosci 22:391-397.
13. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, Itri L, Prange H, Cerami A, Brines M, Siren AL. 2002. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8:495-505.
14. Gibson CL, Jones NC, Prior MJ, Bath PM, Murphy SP. 2005. G-CSF suppresses edema formation and reduces interleukin-1β expression after cerebral ischemia in mice. J Neuropathol Exp Neurol 64:763-769.
15. Hanazono Y, Hosoi T, Kuwaki T, Matsuki S, Miyazono K, Miyagawa K, Takaku F. 1990. Structural analysis of the receptors for granulocyte colony-stimulating factor on neutrophils. Exp Hematol 18:1097-1103.
16. Hallenbeck JH. 2002. The many faces of tumor necrosis factor in stroke. Nat Med 8:1363-1368.
17. Hoehn BD, Palmer TD, Steinberg GK. 2005. Neurogenesis in rats after focal cerebral ischemia is enhanced by indomethacin. Stroke 36:2718-2724.
18. Hunter AJ, Mackay KB, Rogers DC. 1998. To what extent have functional studies of ischaemia in animals been useful in the assessment of potential neuroprotective agents? Trends Pharmacol Sci 19:59-66.
19. Hunter MG, Avalos BR. 1998. Phosphatidylinositol 3′-kinase and SH2-containing inositol phosphate (SHIP) are recruited by distinct positive and negative growth-regulatory domains in the granulocyte colony-stimulating factor. Blood 90:597-604.
20. Iadecola C, Zhang F, Xu X. 1995. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 268:R282-R292.
21. Iadecola C, Zhang F, Casey R, Clark HB, Ross E. 1996. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 27:1373-1380.
22. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME. 1997. Delayed reduction of ischemic brain injury and neurologic deficits in mice lacking the inducible nitric oxide synthase gene. J Neurosci 17:9157-9164.
23. Katsura K, Kristian T, Siesjo BK. 1994. Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem Soc Trans 22:991-996.
24. Komine-Kobayashi M, Zhang N, Liu M, Tanaka R, Hara H, Osaka A, Mochizuki H, Mizuno Y, Urabe T. 2006. Neuroprotective effect of recombinant human granulocyte-stimulating factor in transient focal ischemia of mice. J Cereb Blood Flow Metab 26:402-413.
25. Lee ST, Chu K, Jung KH, Ko SY, Kim EH, Sinn DI, Lee YS, Lo EH, Kim M, Roh JK. 2005. Granulocyte colony-stimulating factor enhances angiogenesis after focal cerebral ischemia. Brain Res 1058:120-128.
26. Li Q, Stephenson D. 2002. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia model in the rat. Exp Neurol 177:531-537.
27. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. 1994. Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 25:1481-1488.
28. Loihl AK, Asensio V, Campbell IL, Murphy SP. 1999. Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Res 830:155-164.
29. Longa EZ, Weinstein PR, Carlson S, Cummis R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91.
30. Martin RL, Lloyd HG, Cowan AI. 1994. The early events of oxygen and glucose deprivation: setting the scene for neuronal death? Trends Neurosci 17:251-257.
31. Minami M, Kuraishi Y, Yabuuchi A, Yamazaki M, Satoh M. 1992. Induction of interleukin-1 mRNA in rat brain after transient forebrain oxygen and glucose deprivation. J Neurochem 58:390-392.
32. Monje ML, Toda H, Palmer TD. 2003. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302:1760-1765.
33. Murphy SJ, Traystman RJ, Hurn PD. 2000. Progesterone exacerbates striatal stroke injury in progesterone-deficient female animals. Stroke 31:1173-1178.
34. Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda N, Nomura H, Ono M. 1986. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319:415-418.
35. Nawashiro H, Martin D, Hallenbeck JM. 1997. Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res 778:265-271.
36. Neidhart J, Mangalik A, Kohler W, Stidley C, Saiki J, Duncan P, Souza L, Downing M. 1989. Granulocyte colony-stimulating factor stimulates recovery of granulocytes in patients receiving dose-intensive chemotherapy without bone marrow transplantation. J Clin Oncol 7:1685-1692.
37. Park EM, Cho S, Frys K, Racchumi G, Zhou P, Anrather J, Iadecola C. 2004. Interaction between inducible nitric oxide synthase and poly (ADP-ribose) polymerase in focal ischemic brain injury. Stroke 35:2896-2901.
38. Park HK, Chu K, Lee ST, Jung KH, Kim EH, Lee KB, Song YM, Jeong SW, Kim M, Roh JK. 2005. Granulocyte colony-stimulating factor induces sensorimotor recovery in intracerebral hemorrhage. Brain Res 1041:125-131.
39. Rothwell NJ, Hopkins SJ. 1995. Cytokines and the nervous system II: actions and mechanisms of action. 18:130-136.
40. Sairanen TR, Lindsberg PJ, Brenner M, Carpen O, Siren A. 2001. Differential cellular expression of tumor necrosis factor-alpha and Type I tumor necrosis factor receptor after transient global forebrain ischemia. J Neurol Sci 186:87-99.
41. Schäbitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Finkelstein SP. 2000. Intravenous brain-derived neurotrophic factor reduces infarct size and counter regulates Bax and Bcl-2 expression after temporary focal cerebral ischemia (editorial comment). Stroke 31:2212-2217.
42. Schäbitz WR, Hoffmann TT, Heiland S, Kollmar R, Barduntzky J, Scholzke MN, Sommer C, Schwab S. 2001. Delayed neuroprotective effect of insulin-like growth factor-1 after experimental transient focal cerebral ischemia. Stroke 32:1226-1233.
43. Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Schölzke MN, Sommer C, Schwab S. 2003. Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34:745-751.
44. Schneider A, Kuhn HG, Schäbitz WR. 2005. A role for G-CSF (granulocyte colony-stimulating factor) in the central nervous system. Cell Cycle 4:1753-1757.
45. Sehara Y, Hayashi T, Deguchi K, Nagotani S, Zhang H, Shoji M, Abe K. 2006. Distribution of inducible nitric oxide synthase and cell proliferation in rat brain after transient middle cerebral artery occlusion. Brain Res 1093:190-197.
46. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, O'Connor M, Green MD, Souza L, Fox RM. 1989. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 2:891-895.
47. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
48. Shimoda K, Feng J, Murakami H, Nagata S, Waiting D, Rogers NC, Stark GR, Kerr IM, Ihle JN. 1997. Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 84:1760-1764.
49. Solaroglu I, Solaroglu A, Kapatanoglu E, Dede S, Haberal A, Beskonakli E, Kiline K. 2003. Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv Syst 19:19-22.
50. Solaroglu I, Cahill J, Jadhav V, Zhang JH. 2006. A novel neuroprotectant granulocyte-colony stimulating factor. Stroke 2006 37:1123-1128.
51. Sprigg N, Bath MP, Zhao L, Willmot MR, Gray JL, Walker MF, Dennis MS, Russell N. 2006. Granulocyte-colony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the stem cell trial of recovery enhancement after stroke (STEMS) pilot randomized, controlled trial. Stroke 37:2979-2983.
52. Sugimoto K, Iadecola C. 2002. Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene. Neurosci Lett 331:25-28.
53. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. 1990. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293.
54. Taupin P. 2006. Neurogenesis in the adult nervous system. C R Biol 329:465-475.
55. Tian SS, Lamb P, Seidel HM, Stein RB, Rosen J. 1994. Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84:1760-1764.
56. Wang X, Feuerstein GZ, Xu L, Wang H, Schumacher WA, Ogletree ML, Taub R, Duan JJ, Decicco CP, Liu RQ. 2004. Inhibition of tumor necrosis factor-alpha-converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats. Mol Pharmacol 65:890-896.
57. Whalen MJ, Carlos TM, Wisniewski SR, Clark RS, Mellick JA, Marion DW, Kochanek PM. 2000. Effect of neutropenia and granulocyte colony-stimulating factor-induced neutrophilia on blood-brain barrier permeability and brain edema after traumatic brain injury in rats. Crit Care Med 28:3710-3717.
58. Zaremba J, Losy J. 2001. Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand 104:288-295.
59. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q, Lu M, Chopp M. 2002. A test of detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Method 117:207-214.
60. Zhu DY, Deng Q, Yao HH, Wang DC, Deng Y, Liu GQ. 2002. Inducible nitric oxide synthase expression in the ischemic core and penumbra after transient cerebral ischemia in mice. Life Sci 17:1985-1996.